Peter Attia· MD
month you can start to see consequences of torque 2 inhibition with arapalog alone and it's reflected in hyperglycemia and hypertroglyceridemia so biomarkers in the peripheral blood you can measure
The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
month you can start to see consequences of torque 2 inhibition with arapalog alone and it's reflected in hyperglycemia and hypertroglyceridemia so biomarkers in the peripheral blood you can measure
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
if we took non-diabetic non-immuno-compromised quote-unquote as normal as possible subjects do we have evidence that those things happen